FDA to evaluate psychedelic MDMA for the first time for the treatment of PTSD
A panel of advisers from the US Food and Drug Administration is meeting to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The…
Psychedelic drug MDMA raises questions as FDA considers approval for PTSD
WASHINGTON — Federal health authorities are questioning the safety and evidence behind the first attempt to use MDMA, the mind-altering club drug, as a treatment for PTSD. This is part…
